(CBT) Cabot - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1270551013
CBT: Specialty Chemicals, Performance Materials
Cabot Corporation (NYSE:CBT) is a global leader in specialty chemicals and performance materials, operating through two core segments: Reinforcement Materials and Performance Chemicals. The company specializes in advanced materials solutions for industrial and consumer applications. Its product portfolio includes reinforcing carbons, engineered elastomer composites, specialty carbons, fumed silica, fumed alumina, aerogel, masterbatch and conductive compounds, inkjet colorants, carbon nanotubes, and fumed metal oxides. These materials are integral to a wide range of industries, including automotive, electronics, energy storage, construction, cosmetics, and consumer goods. Cabots products enhance performance, durability, and efficiency in applications such as tires, batteries, adhesives, coatings, and thermal insulation. With a global distribution network spanning the Americas, Europe, the Middle East, Africa, and Asia Pacific, the company serves a diverse customer base. Founded in 1882 and headquartered in Boston, Massachusetts, Cabot Corporation has established itself as a key player in the specialty chemicals sector.
Based on the provided
Additional Sources for CBT Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CBT Stock Overview
Market Cap in USD | 4,229m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Commodity Chemicals |
IPO / Inception | 1980-11-05 |
CBT Stock Ratings
Growth Rating | 57.9 |
Fundamental | 72.2 |
Dividend Rating | 61.0 |
Rel. Strength | -21.1 |
Analysts | 3.6/5 |
Fair Price Momentum | 72.62 USD |
Fair Price DCF | 176.81 USD |
CBT Dividends
Dividend Yield 12m | 2.02% |
Yield on Cost 5y | 6.06% |
Annual Growth 5y | 3.84% |
Payout Consistency | 89.5% |
CBT Growth Ratios
Growth Correlation 3m | -87.6% |
Growth Correlation 12m | -57.4% |
Growth Correlation 5y | 93.8% |
CAGR 5y | 21.22% |
CAGR/Max DD 5y | 0.57 |
Sharpe Ratio 12m | -1.80 |
Alpha | -35.11 |
Beta | 0.887 |
Volatility | 47.29% |
Current Volume | 680.8k |
Average Volume 20d | 425.4k |
As of May 09, 2025, the stock is trading at USD 74.31 with a total of 680,826 shares traded.
Over the past week, the price has changed by -3.77%, over one month by -0.66%, over three months by -13.49% and over the past year by -25.19%.
Yes, based on ValueRay Fundamental Analyses, Cabot (NYSE:CBT) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 72.15 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CBT as of May 2025 is 72.62. This means that CBT is currently overvalued and has a potential downside of -2.27%.
Cabot has received a consensus analysts rating of 3.60. Therefor, it is recommend to hold CBT.
- Strong Buy: 2
- Buy: 0
- Hold: 2
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, CBT Cabot will be worth about 80.2 in May 2026. The stock is currently trading at 74.31. This means that the stock has a potential upside of +7.87%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 91 | 22.5% |
Analysts Target Price | 111 | 49.4% |
ValueRay Target Price | 80.2 | 7.9% |